Optimal different adeno-associated virus capsid/promoter combinations to target specific cell types in the common

Yasunori Matsuzaki1,2, Yuuki Fukai1, Ayumu Konno1,2

  • 1Department of Neurophysiology & Neural Repair, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

Insights

This study identifies optimal adeno-associated virus (AAV) capsid and promoter combinations for cell-type-specific gene expression in marmoset brains. Researchers found specific AAVs for targeting neurons, astrocytes, and oligodendrocytes, crucial for neuroscience research.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Gene Therapy

Background:

  • Adeno-associated virus (AAV) vectors are crucial for gene delivery in neuroscience research.
  • Understanding AAV tropism in nonhuman primate brains is essential for targeted gene expression.
  • Previous studies have limited data on AAV tropism across diverse brain cell types in primates.

Purpose of the Study:

  • To elucidate the tropism of nine adeno-associated virus (AAV) serotype capsids in marmoset cerebral cortical cells.
  • To identify optimal AAV capsid and promoter combinations for cell-type-specific gene expression in the primate brain.
  • To guide the development of targeted gene therapies and neuroscience research tools.

Main Methods:

  • In vivo assessment of nine AAV serotype capsids (AAV1, 2, 5, 6, 7, 8, 9, rh10, DJ) expressing EGFP in marmoset cerebral cortex.
  • Utilized ubiquitous promoters (CBh, CMV, CAG) and cell-type-specific promoters (hGFA, mMBP).
  • Analyzed EGFP expression patterns in neurons, astrocytes, and oligodendrocytes.

Main Results:

  • AAV9 and AAVrh10 capsids demonstrated high neuron-selective EGFP expression with ubiquitous promoters.
  • AAV2 and AAV7 capsids combined with the hGFA promoter showed selective EGFP expression in astrocytes.
  • AAV5 capsids with the mMBP promoter efficiently targeted oligodendrocytes for EGFP expression.

Conclusions:

  • Established optimal AAV capsid-promoter pairings for neuron-, astrocyte-, and oligodendrocyte-specific gene expression in marmosets.
  • AAV9/rh10 with CBh/CMV for neurons, AAV2/7 with hGFA for astrocytes, and AAV5 with mMBP for oligodendrocytes are recommended.
  • Findings provide critical insights for advancing targeted gene therapy and functional studies in the primate brain.

Related Concept Videos